Autolus

Chris Vann, Senior Vice President and Chief Operating Officer

April 21 | 11:30am | Gaudi 3 Ballroom

London, United Kingdom

(NASDAQ: AUTL)

In-Person Presentation

Autolus is a leader in T cell programming technologies and believes its leadership will provide a competitive advantage as it looks to develop future generations of T cell therapies targeting both hematological cancers and solid tumors.

www.autolus.com



By using this website you agree to accept our Privacy Policy and Terms & Conditions